Vivian Fonseca, MD

Vivian Fonseca, MD

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine
American Diabetes Association

Related Videos

You have made the case for a call-to-action to treat LDL-C very aggressively in diabetic patients with known ASCVD. What is your rationale for this and how do the recent rials support your recommendation to treat diabetics with ASCVD aggressively? Video

You have made the case for a call-to-action to treat LDL-C very aggressively in diabetic patients with known ASCVD. What is your rationale for this and how do the recent rials support your recommendation to treat diabetics with ASCVD aggressively?

What is the unmet need for residual CV risk reduction in post-ACS patients with T2D? In your role as a member of the LDL Guideline Group for AACE, what were the implications of treating diabetic patients with so-called “extreme risk”?” Video

What is the unmet need for residual CV risk reduction in post-ACS patients with T2D? In your role as a member of the LDL Guideline Group for AACE, what were the implications of treating diabetic patients with so-called “extreme risk”?”